<DOC>
	<DOCNO>NCT02535845</DOCNO>
	<brief_summary>HPV vaccine coverage among adolescent US suboptimal . This particularly true among traditionally underserved adolescent . Few parent-targeted intervention focus parental decision-making process . Self-persuasion , generate one 's argument engage behavior , may effective mean influence parent ' motivation vaccinate child . In three-phase study , investigator use quantitative qualitative research method develop refine tablet-based self-persuasion intervention parent undecided HPV vaccine . This clinical trial submission focus third phase study ( second stage also register clinical trial ) .</brief_summary>
	<brief_title>Developing Self-persuasion Intervention Promoting Adolescent HPV Vaccination : Feasibility Trial</brief_title>
	<detailed_description>Despite fact HPV vaccination recommend male female adolescent , HPV vaccine coverage among adolescent age 13-17 poor ( 60 % girl , 41.7 % boy ) . HPV-related cancer significant burden US healthcare system could prevent adolescent vaccination . Rates vaccination suboptimal among underserved population ( uninsured , low-income , racial ethnic minority ) often see safety-net clinic . Few intervention design target decision-making among parent unvaccinated adolescent . Self-persuasion , generate one 's argument health behavior , may effective mean influence HPV vaccination behavior among undecided ambivalent parent . Through three stage , investigator identify develop self-persuasion intervention strategy promote adolescent HPV vaccination safety-net clinic . In Stage 3 , report , investigator conduct two-arm pilot randomize control trial safety-net clinic assess feasibility test self-persuasion intervention condition identify Stage 2 standard care ( control group ) . Investigators also examine impact intervention parent-provider discussion HPV vaccination .</detailed_description>
	<criteria>Undecided parent 1117 year old patient begin HPV vaccine series . Pregnant adolescent Lack telephone access Having impair hear speech Phase 1 2 participant exclude participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>